¶ CFLAR (CASP8 and FADD-like Apoptosis Regulator) Protein
CFLAR (also known as c-FLIP, Cellular FLICE-like Inhibitory Protein) is a master regulator of extrinsic apoptosis and necroptosis that plays a critical role in determining cell survival or death in neurons. This protein is particularly important in neurodegenerative diseases where dysregulated cell death pathways contribute to neuronal loss.
| Property |
Value |
| Protein Name |
CFLAR (Cellular FLICE-like Inhibitory Protein) |
| Gene |
CFLAR |
| UniProt ID |
O15519 |
| PDB IDs |
2RJ8, 3H11, 4ZGM |
| Molecular Weight |
55-60 kDa (isoform dependent) |
| Subcellular Localization |
Cytoplasm, nucleus |
| Protein Family |
Death effector domain (DED) family |
| Aliases |
c-FLIP, FLICE-inhibitory protein, Usurpin |
CFLAR is structurally similar to caspase-8 but lacks catalytic activity. The protein contains:
- Two Death Effector Domains (DEDs): The N-terminal DEDs mediate interactions with FADD and caspase-8 at the DISC (Death-Inducing Signaling Complex)
- Multiple Splice Variants:
- c-FLIP_L (long isoform): Full-length form with two DEDs
- c-FLIP_S (short isoform): Dominant negative inhibitor
- c-FLIP_R: Rare isoform with unique properties
- Serine/Threonine-rich C-terminal region: Contains phosphorylation sites that regulate protein function
CFLAR primarily functions as an endogenous inhibitor of the extrinsic apoptosis pathway:
- DISC Assembly Regulation: c-FLIP competes with caspase-8 for binding to FADD's DEDs, preventing caspase-8 activation [1]
- Heterozyme Complex Formation: c-FLIP_L can form heterodimers with caspase-8, altering its substrate specificity [2]
- Blockade of Apoptosis Execution: By preventing caspase-8 activation, c-FLIP blocks downstream effector caspase activation and apoptosis
CFLAR interacts with multiple components of the NF-κB signaling pathway:
- Pro-survival signaling: NF-κB activation promotes expression of anti-apoptotic genes
- Crosstalk with death receptors: FLIP modulates both death receptor signaling and survival pathways
- Kinase interactions: Associates with RIPK1 and affects necroptosis signaling
CFLAR interacts with key autophagy regulators:
- Direct interaction with Beclin-1: Modulates autophagy initiation
- LC3 lipidation: Influences autophagosome formation
- Dual role: Can both promote and inhibit autophagy depending on cellular context
CFLAR blocks the necroptosis pathway by:
- Inhibiting RIPK1 activation: Prevents formation of the necrosome
- Modulating RIPK3 interactions: Affects MLKL recruitment and activation
In Alzheimer's disease, CFLAR expression is modulated by amyloid-beta toxicity:
- Amyloid-beta induced upregulation: Neurons increase c-FLIP expression as a protective response [3]
- Anti-apoptotic function: c-FLIP protects against Aβ-induced caspase-8 activation [4]
- Therapeutic implications: Enhancing c-FLIP expression may provide neuroprotection
In Parkinson's disease, CFLAR protects dopaminergic neurons:
- Protection against MPTP toxicity: c-FLIP overexpression protects against MPTP-induced parkinsonism [5]
- Modulation of mitochondrial apoptosis: Interacts with Bcl-2 family proteins
- DJ-1 interaction: Partners with DJ-1 (parkinsonism-associated protein) in neuroprotection
¶ Stroke and Ischemia
Following cerebral ischemia:
- Ischemic preconditioning: Upregulation of c-FLIP mediates neuroprotection [6]
- Reperfusion injury: Modulates death receptor signaling during reperfusion
- Therapeutic window: Timing of c-FLIP modulation critical for outcomes
In ALS:
- Altered expression patterns: c-FLIP levels changed in motor neuron disease
- Excitotoxicity modulation: Links glutamate excitotoxicity to apoptosis
- SOD1 mutations: Interaction with mutant SOD1 toxicity pathways
CFLAR contributes to neuroinflammation regulation:
- Microglial activation: Modulates microglial cell death decisions
- T-cell survival: Affects immune cell viability in CNS autoimmunity
Modulating CFLAR represents a therapeutic strategy:
- Neuroprotective agents: Compounds that upregulate c-FLIP expression
- Combination therapies: c-FLIP modulation with other anti-apoptotic proteins
- Drug development: Small molecules targeting FLIP-caspase-8 interactions
While CFLAR is extensively studied in cancer (where high expression confers chemoresistance), the same anti-apoptotic mechanisms that make it a cancer therapeutic target make it relevant for neuroprotection [7].
CFLAR interacts with multiple key proteins:
| Partner Protein |
Interaction Type |
Functional Consequence |
| FADD |
Direct binding |
DISC assembly modulation |
| Caspase-8 |
Heterodimerization |
Enzyme activity inhibition |
| RIPK1 |
Direct binding |
Necroptosis regulation |
| RIPK3 |
Indirect |
Necrosome formation |
| NF-κB |
Signaling cascade |
Survival gene expression |
| Beclin-1 |
Direct binding |
Autophagy modulation |
| Bcl-2 |
Functional crosstalk |
Mitochondrial apoptosis |